Stockscreener 앱 받기
18.94
0.26%
0.05
시간 외 거래:
18.94
전일 마감가:
$18.89
열려 있는:
$18.84
하루 거래량:
1.62M
Relative Volume:
0.58
시가총액:
$2.43B
수익:
$745.97M
순이익/손실:
$-99.21M
주가수익비율:
-24.51
EPS:
-0.7729
순현금흐름:
$-5.09M
1주 성능:
+7.25%
1개월 성능:
+18.82%
6개월 성능:
+129.85%
1년 성능:
+137.05%
1일 변동 폭
$18.77
$19.38
1주일 범위
$17.21
$19.38
52주 변동 폭
$7.065
$19.76
Neogenomics Inc Stock (NEO) Company Profile
명칭
Neogenomics Inc
전화
(239) 768-0600
주소
9490 NEOGENOMICS WAY, FORT MYERS, FL
Compare NEO vs TMO, DHR, NTRA, IQV, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
18.94 | 2.23B | 745.97M | -99.21M | -5.09M | -0.7729 |
TMO
Thermo Fisher Scientific Inc
|
648.43 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
208.36 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
345.34 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
268.82 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
153.69 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-07-29 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | 개시 | Guggenheim | Neutral |
| 2025-04-30 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 개시 | Jefferies | Buy |
| 2024-05-01 | 재개 | Craig Hallum | Buy |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-08-21 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-02-24 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-02-01 | 업그레이드 | Needham | Hold → Buy |
| 2022-08-26 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-22 | 다운그레이드 | Needham | Buy → Hold |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-03-29 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-03-29 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 재개 | Stephens | Overweight |
| 2021-12-16 | 개시 | Cowen | Outperform |
| 2021-11-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-02-25 | 재개 | Needham | Buy |
| 2021-02-25 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-12-11 | 재개 | BTIG Research | Buy |
| 2020-10-28 | 재확인 | Needham | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-08-28 | 개시 | Guggenheim | Buy |
| 2020-07-29 | 재확인 | Needham | Buy |
| 2020-06-25 | 개시 | BofA/Merrill | Buy |
| 2020-04-21 | 재개 | Stephens | Overweight |
| 2020-03-02 | 재개 | Craig Hallum | Buy |
| 2020-02-28 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | 다운그레이드 | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-05-01 | 재확인 | Needham | Buy |
| 2019-03-29 | 재확인 | Needham | Buy |
| 2019-01-03 | 개시 | Needham | Buy |
| 2018-10-24 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 개시 | Leerink Partners | Outperform |
| 2018-05-02 | 다운그레이드 | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2017-08-24 | 개시 | Gabelli & Co | Buy |
| 2016-12-15 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Neogenomics Inc 주식(NEO)의 최신 뉴스
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
(NEO) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
A Look Back at Testing & Diagnostics Services Stocks’ Q2 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack - Yahoo Finance
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
NeoGenomics, Inc. $NEO Shares Bought by First Light Asset Management LLC - MarketBeat
NeoGenomics Inc. (NEO) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
NeoGenomics EVP Alicia Olivo Surrenders Shares for Tax Withholding Following Restricted Stock Vesting - Kalkine Media
Bank of New York Mellon Corp Takes Position in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire
Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO), LeonaBio (LONA) and Solid Biosciences (SLDB) - The Globe and Mail
NeoGenomics Shares Rise After RaDaR ST Assay Gets Expanded Medicare Coverage - marketscreener.com
NeoGenomics Stock Just Turned Its First Profit, Creating an Optimal Entry Point - inkl
NeoGenomics gains Medicare coverage for cancer MRD test By Investing.com - Investing.com Canada
NeoGenomics RaDaR ST wins expanded Medicare coverage for immunotherapy response monitoring - Bitget
NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring - Yahoo Finance
NeoGenomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Court Win Over Natera Patents Could Be A Game Changer For NeoGenomics’ (NEO) RaDaR ST - simplywall.st
NeoGenomics, Inc. (NEO) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
NeoGenomics (NASDAQ:NEO) Healthcare Innovation Gains Attention - Kalkine Media
NeoGenomics (NASDAQ:NEO) Reaches New 12-Month HighHere's Why - MarketBeat
Neogenomics stock hits 52-week high at 16.93 USD By Investing.com - Investing.com Nigeria
Neogenomics stock hits 52-week high at 16.93 USD - Investing.com
NeoGenomics, Inc. Revenue Breakdown – NASDAQ:NEO - TradingView
NeoGenomics (NEO) Advances 1.44% to $16.17 as Buyers Hold Above Key SupportPercent Above MA - vinanet.vn
NeoGenomics (NASDAQ:NEO) Enters A New Growth Spotlight - Kalkine Media
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Neogenomics Stock Price Forecast. Should You Buy NEO? - StockInvest.us
NeoGenomics (NEO) stake tops 8% for First Light’s Mathew Arens - Stock Titan
NeoGenomics | SCHEDULE 13G/A: Others - Moomoo
California State Teachers Retirement System Raises Position in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics, Inc. (NEO) Stock Forecasts - Yahoo Finance
NeoGenomics Senior VP & Chief Accounting Officer Gregory Aunan Sells 80% Of Holding - simplywall.st
GC To Depart Cancer Diagnostic Co. NeoGenomics - Law360
Renaissance Technologies LLC Acquires New Shares in NeoGenomics, Inc. $NEO - MarketBeat
Form 8K NeoGenomics Inc For: 11 August By Investing.com - Investing.com India
Technical Reactions to NEO Trends in Macro Strategies - Stock Traders Daily
NeoGenomics announces planned departure of General Counsel Alicia Olivo - Investing.com
NeoGenomics (NEO) Slips to $16.50 as Biotech Diagnostic Stocks Face Cautious TradingVWAP Deviation - Vinanet
NeoGenomics (NASDAQ:NEO) Sets New 1-Year HighShould You Buy? - MarketBeat
MFG Wealth Management Inc. Takes Position in NeoGenomics, Inc. $NEO - marketbeat.com
NeoGenomics, Inc. (NEO) Stock forecasts - Yahoo Finance Australia
Has NeoGenomics (NEO) Priced In Its Turnaround Following Q2 Profitability? - simplywall.st
NeoGenomics (NEO) Is Up 8.4% After Q2 Profit Return And Raised 2026 Outlook – Has The Bull Case Changed? - finance.yahoo.com
Neogenomics stock hits 52-week high at 16.46 USD By Investing.com - Investing.com UK
Neogenomics stock hits 52-week high at 16.46 USD - Investing.com
NEOUSD (NEOUSD) Stock News Today - TradingKey
NeoGenomics Appoints Carolyn Starrett to its Board of Directors - The National Law Review
NeoGenomics, Inc. $NEO Stock Position Raised by Sei Investments Co. - MarketBeat
Dimensional Fund Advisors LP Buys 225,588 Shares of NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics, Inc. Revenue Breakdown – BX:NG9 - TradingView
NeoGenomics Laboratories Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
Neogenomics Inc (NEO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
자본화:
|
볼륨(24시간):